New and novel antidotes in pediatrics.
Article Details
- CitationCopy to clipboard
Calello DP, Osterhoudt KC, Henretig FM
New and novel antidotes in pediatrics.
Pediatr Emerg Care. 2006 Jul;22(7):523-30.
- PubMed ID
- 16871118 [ View in PubMed]
- Abstract
Antidotal therapy can be lifesaving in the management of poisoned children. Although supportive care is sufficient in many cases, a specific antidote can significantly reduce morbidity and mortality in a number of poisoning scenarios, and so the pediatric emergency medicine practitioner must be familiar with its indications for use, dosage and administration, and contraindications. A number of new antidotes have emerged in recent years. This review discusses the pediatric uses and limitations of intravenous N-acetylcysteine, octreotide, crotaline Fab antivenom, fomepizole, atropine and pralidoxime autoinjectors and provides some brief discussion on newer antidotes for which data is only starting to emerge.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Fomepizole Alcohol dehydrogenase 1A Protein Humans YesInhibitorDetails Fomepizole Alcohol dehydrogenase 1B Protein Humans YesInhibitorDetails Fomepizole Alcohol dehydrogenase 1C Protein Humans YesInhibitorDetails